Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of ($0.38), $0.21 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $65.7 million versus the consensus estimate of $94.71 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.